7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Viking Therapeutics, Inc
(NASDAQ:VKTX) 

VKTX stock logo

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TR), ...

Founded: 2012
Full Time Employees: 17
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Viking Therapeutics Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01,341.432,682.864,024.295,365.716,707.148,048.579,390
Viking Therapeutics Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.8-0.68-0.57-0.46-0.34-0.23-0.110
Viking Therapeutics Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.8-0.68-0.57-0.46-0.34-0.23-0.110
Viking Therapeutics Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.571.131.72.272.833.43.97
Viking Therapeutics P/S ratio ttm
202110 202111 202112 202201 202202 202203 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 06,367.2312,734.4719,101.725,468.9431,836.1738,203.4144,570.64Billion
Viking Therapeutics (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -100.5-86.15-71.79-57.43-43.07-28.72-14.360
Viking Therapeutics P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 03.5710.4913.9917.4920.9924.49
No extra charts and metrics for this ticker.